Background: The COVID-19 pandemic strained hospital resources in New York City, including those for providing dialysis. NYU Medical Center and affiliations, including NYC Health and Hospitals/Bellevue (BH), developed a plan to offset the increased needs for kidney replacement therapy (KRT). We established acute peritoneal dialysis (PD) capability, as usual dialysis modalities were overwhelmed by COVID-19 acute kidney injury (AKI). Methods: Observational study of patients requiring KRT admitted to Bellevue Hospital during the COVID surge. Bellevue Hospital is one of the largest public hospitals in the country, providing medical care to an underserved population. There were substantial staff, supplies, and equipment shortages. Admitted adult patients with acute kidney injury (AKI) who required KRT were considered for PD. We rapidly established an acute PD program. A surgery team placed catheters at the bedside in the intensive care unit; a nephrology team delivered treatment. We provided an alternative to hemodialysis and continuous veno-venous hemofiltration for treating intensive care unit patients, demonstrating efficacy with outcomes comparable to standard care. Results: From April 8, 2020 to May 8, 2020, 39 catheters were placed into 10 women and 29 men. By June 10, 39% of the patients started on PD recovered kidney function (average ages 56 (men) and 59.5 (women) years); men and women who expired were average 71.8 and 66.2 years. No episodes of peritonitis observed; nine incidents of minor leaking. Some patients were treated while ventilated in the prone position. Conclusions: Demand compelled us to utilize acute PD during the COVID-19 pandemic. Our experience is one of the largest recently reported in the United States of which we are aware. Acute PD provided lifesaving care to acutely ill patients when expanding current resources was impossible. Our experience may help other programs to avoid rationing of dialysis treatments in health crises.